|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 2 | 06-Feb-2024 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 06-Feb-2024 | active |
| Disorder of kidney due to diabetes mellitus | 29-Mar-2022 | active |
| Chronic kidney disease stage 1 | 29-Mar-2022 | active |
| Essential hypertension | 16-Dec-2003 | active |
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-04-15 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Hydrochlorothiazide 25 mg oral tablet | 2025-04-15 | - | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2025-04-15 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| Vaccine | Date |
|---|---|
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 28-Jan-2025 |
| Influenza virus antigen only vaccine product | 28-Jan-2025 |
| SARS-CoV-2 mRNA vaccine | 09-Mar-2021 |
| Procedure | Date | Reason |
|---|---|---|
| Suture open wound | 23-Apr-2024 | Laceration of thigh |
| Depression screening | 13-Dec-2022 | - |
| Medication reconciliation | 13-Dec-2022 | - |
| Assessment of health and social care needs | 13-Dec-2022 | - |
| Assessment of anxiety | 13-Dec-2022 | - |
| Screening for domestic abuse | 13-Dec-2022 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 13-Dec-2022 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 29-Nov-2022 | - |
| Assessment of substance use | 29-Nov-2022 | - |
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| Inadequate digital access affecting health care | 2025-10-22 | active | environment |
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Lifestyle education regarding hypertension | 16-Dec-2003 | Essential hypertension (disorder) |
|
||
| Routine antenatal care | 09-Jan-1996 | - |
| Vital Signs | 2025-04-15 | 2025-01-28 |
|---|---|---|
| Body Height | 172.4 cm | 172.4 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 1 {score} |
| Body Weight | 102.9 kg | 102.9 kg |
| Body mass index (BMI) [Ratio] | 34.6 kg/m2 | 34.6 kg/m2 |
| Diastolic Blood Pressure | 79 mm[Hg] | 79 mm[Hg] |
| Systolic Blood Pressure | 103 mm[Hg] | 94 mm[Hg] |
| Heart rate | 72 /min | 87 /min |
| Respiratory rate | 14 /min | 14 /min |
| Recent Lab Observations | 15-APR-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 74.5 | 70 - 139 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 7.7 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.0 H | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 9.5 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 138.4 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 4.3 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 101.8 | 98 - 110 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 22.7 | 22 - 32 | mmol/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 2.4 H | 0 - 0 | mg/dL |
| Glucose [Presence] in Urine by Test strip | ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 1.4 | 0 - 1.6 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 14.2 H | 0 - 0.5 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = + | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.03 | {nominal} |
| pH of Urine by Test strip | 6.7 | 4.5 - 7.5 | pH |
| Protein [Mass/volume] in Urine by Test strip | 169.0 H | 0 - 15 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = ++ | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative |